Journals / Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.) / 2009 / Cilt: 20 - Sayı: 3

Gaucher hastalığında femoral kompresyon nöropatisine neden olan pelvis içi kitle: Olgu sunumu

Intrapelvic mass causing femoral compression neuropathy in a patient with Gaucher disease: A case report

Pages
169–173
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The neurological impairment caused by compression by a tumor should be distinguished from the ones reported in neurogenic forms of the disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gaucher disease is a lysosomal storage disorder in which glucocerebroside accumulates within the macrophages in any part of the body.
📊
Key Findings & Data:We present a 38-year-old female patient with Gaucher disease who had a large intrapelvic mass originating from left iliac bone causing femoral compression neuropathy.
💡
Conclusion & Impact:The neurological impairment caused by compression by a tumor should be distinguished from the ones reported in neurogenic forms of the disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gaucher disease is a lysosomal storage disorder in which glucocerebroside accumulates within the macrophages in any part of the body. Varying degrees of skeletal involvement may occur besides anemia, coagulation abnormalities and hepatosplenomegaly. Most of the factors influencing the quality of life in a patient with Gaucher disease are related to bone involvement. Gaucher cell deposits may extrude through cortical erosions and cause soft tissue masses around bones which are involved by the disease. We present a 38-year-old female patient with Gaucher disease who had a large intrapelvic mass originating from left iliac bone causing femoral compression neuropathy. The classification of disease is based on neurological involvement and if symptoms exist whether the symptoms are acute or subacute. The neurological impairment caused by compression by a tumor should be distinguished from the ones reported in neurogenic forms of the disease.

Özet

Gaucher hastalığı, glukoserebrositlerin, vücudun herhangi bir yerinde makrofajların içinde biriktiği lizozomal depo hastalığıdır. Anemi, koagülasyon anomalileri ve hepatosplenomegalinin yanı sıra farklı derecede iskelet tutulumu hastalığa eşlik edebilir. Gaucher hastalığında yaşam kalitesini etkileyen faktörler kemik tutulumu ile ilişkilidir. Hastalık kaynaklı Gaucher hücre birikintileri kortikal erozyonlardan kemik dışına çıkabilir ve kemiklerin çevresinde yumuşak doku kitleleri oluşturabilir. Bu makalede, sol iliyak kanattan köken alan femoral kompresyon nöropatisine neden olacak kadar büyük bir pelvis içi kitle oluşumu tespit ettiğimiz 38 yaşında kadın olgu sunuldu. Hastalık nörolojik tutuluma göre ve eğer nörolojik belirtiler varsa bunların akut veya subakut olmalarına göre sınıflandırılmaktadır. Tümör basısı ile ortaya çıkan nörolojik bir bozukluk, hastalık için tanımlanmış olan nörojenik formlardan ayırt edilmelidir.

🔖

Cite This Article

AYAN, İ., KUYURTAR, F., ÇOLAK, M., CANBAZ, H., KARABACAK, T. (2022). Gaucher hastalığında femoral kompresyon nöropatisine neden olan pelvis içi kitle: Olgu sunumu. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), Cilt: 20 - Sayı: 3, 169–173. https://ajindex.com/articles/498741

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Beutler E Gaucher disease in lipid storage disorders. In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal J, editors. Williams hematology. 7th ed. New York: McGraw-Hill; 2006. p. 1009-14
  2. Jmoudiak M, Itzchaki M, Hadas-Halpern I, Hrebicek M, Hodanova K, Elstein D, et al. Iliopsoas hematoma in a young patient with type I Gaucher disease. Isr Med Assoc J 2003;5:673-4
  3. Hermann G, Pastores GM, Abdelwahab IF, Lorberboym AM. Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement. Skeletal Radiol 1997;26:687-96
  4. Barone R, Pavone V, Nigro F, Chabàs A, Fiumara A Extraordinary bone involvement in a Gaucher disease type I patient. Br J Haematol 2000;108:838-41
  5. Kaloterakis A, Cholongitas E, Pantelis E, Papadimitriou C, Durakis S, Filiotou A. Type I Gaucher disease with severe skeletal destruction, extraosseous extension, and monoclonal gammopathy. Am J Hematol 2004;77:377-80
  6. Poll LW, Koch JA, vom Dahl S, Loxtermann E, Sarbia M, Niederau C, et al. Extraosseous manifestation of Gaucher’s disease type I: MR and histological appearance. Eur Radiol 2000;10:1660-3
  7. Vellodi A, Bembi B, de Villemeur TB, Collin-Histed T, Erikson A, Mengel E, et al. Management of neuronopathic Gaucher disease: a European consensus. J Inherit Metab Dis 2001;24:319-27
  8. Tayebi N, Stone DL, Sidransky E. Type 2 Gaucher disease: an expanding phenotype. Mol Genet Metab 1999; 68:209-199
  9. Brady RO, Barton NW, Grabowski GA. The role of neurogenetics in Gaucher disease. Arch Neurol 1993; 50:1212-24
  10. Weinreb N, Barranger J, Packman S, Prakash-Cheng A, Rosenbloom B, Sims K, et al. Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease. Clin Genet 2007;71:576-88
  11. Hermann G, Goldblatt J, Levy RN, Goldsmith SJ, Desnick RJ, Grabowski GA. Gaucher’s disease type 1: assessment of bone involvement by CT and scintigraphy. AJR Am J Roentgenol 1986;147:943-8
  12. Hollak CE, Levi M, Berends F, Aerts JM, van Oers MH. Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy. Br J Haematol 1997;96:470-6
  13. Giraldo P, Solano V, Pérez-Calvo JI, Giralt M, RubioFélix D; Spanish Group on Gaucher disease. Quality of life related to type 1 Gaucher disease: Spanish experience. Qual Life Res 2005;14:453-62.